APTAMER SCIENCES INC has a total of 11 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are QUANTUMCYTE INC, ONCOTYROL CT FOR PERSONALIZED CANCER MEDICINE GMBH and TEIKYO UNIVERSITY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kim Youndong | 5 |
#2 | Ostroff Rachel M | 4 |
#3 | Zichi Dominic Anthony | 4 |
#4 | Katilius Evaldas | 4 |
#5 | Kim Kiseok | 4 |
#6 | Shin Euisu | 4 |
#7 | Seok Minkyoung | 3 |
#8 | Ryu Sung Ho | 3 |
#9 | Jung Jongha | 3 |
#10 | Kang Juhyung | 2 |
Publication | Filing date | Title |
---|---|---|
KR102154683B1 | Glypican-3 specific modified aptamer and uses thereof | |
KR20200095870A | Multiplex PCR method using Aptamer | |
WO2019039863A2 | Method for preparing aptamer using surrogate virus | |
WO2019216458A1 | Aptamer against insulin receptor, and pharmaceutical composition for treating diabetes, comprising same | |
KR20180119758A | White blood cell specific aptamer and the use thereof | |
KR20180036787A | Protein biomarker panel for non-small cell lung cancer diagnosis and non-small cell lung cancer diagnosis method using the same |